Keywords: Diagnosis/Prediction, Radiomics, Gliomas
Motivation: The IDH1 mutant state is an independent risk factor of affecting the treatment and prognosis of glioma. Predicting the IDH1 status accurately pre-operator is crucial for making personalized treatment decisions for glioma patients.
Goal(s): This study aims to propose a non-invasive and convenient model based on MRI to predict the IDH1 status of gliomas before operation accurately.
Approach: Building three machine learning models based on multi-sequence MRI radiomics features, VASARI features, and combined features to predict the IDH1 status.
Results: These three models can predict the IDH1 status effectively and accurately, the combined model has the best diagnostic performance.
Impact: Models based on conventional MRI sequences and VASARI features provide the clinical value for evaluation of molecular typing in gliomas. It is expected to become a practical tool for the non-invasive characterization of gliomas to help the individualized treatment planning.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords